SCHEMBL7148205

SCHEMBL7148205

Nc1cccc(C(O)(CCN(Cc2ccccc2)Cc2ccccc2)c2cccc(N)c2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.43
MAOB P27338 3/20 0.40
MAOA P21397 2/20 0.40
CCR2 P41597 1/20 0.40
OPRK1 P41145 3/20 0.39
OPRM1 P35372 2/20 0.39
OPRD1 P41143 2/20 0.39
SIGMAR1 Q99720 1/20 0.39
HTT P42858 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7615169 0.85 MEN1 (0.43) MEN1KMT2AMAOBMAOACCR2
SCHEMBL6326374 0.84 SMN1; SMN2 (0.46) MEN1KMT2ASMN1; SMN2MAOBMAOA
SCHEMBL7024973 0.83 MEN1 (0.48) MEN1KMT2ASMN1; SMN2MAOBOPRK1
SCHEMBL6320217 0.75 SMN1; SMN2 (0.46) MEN1KMT2ASMN1; SMN2OPRK1OPRM1
SCHEMBL7032860 0.74 SMN1; SMN2 (0.43) MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL11125959 0.74 SMN1; SMN2 (0.57) MEN1KMT2ASMN1; SMN2OPRK1SIGMAR1
SCHEMBL17073435 0.72 SIGMAR1 (0.49) SMN1; SMN2CCR2OPRM1SIGMAR1TSHR
SCHEMBL31067545 0.72 SIGMAR1 (0.49) SMN1; SMN2CCR2OPRM1SIGMAR1TSHR
SCHEMBL6320470 0.71 CALM1 (0.47) MEN1KMT2ASMN1; SMN2OPRK1SIGMAR1
SCHEMBL17065048 0.71 CHRM3 (0.52) SMN1; SMN2CCR2OPRM1SIGMAR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030032834-A1 Aminoalcohol derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030032834-A1 Aminoalcohol derivatives ADRB1, ADRB2, ADRB3 MEN1 4166/4885KMT2A 3486/4885SMN1; SMN2 3568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.